These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7793896)

  • 1. nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.
    Fukuda H; Hosaka M; Iyobe S; Gotoh N; Nishino T; Hirai K
    Antimicrob Agents Chemother; 1995 Mar; 39(3):790-2. PubMed ID: 7793896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.
    Fukuda H; Hosaka M; Hirai K; Iyobe S
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1757-61. PubMed ID: 2126688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
    Chamberland S; Bayer AS; Schollaardt T; Wong SA; Bryan LE
    Antimicrob Agents Chemother; 1989 May; 33(5):624-34. PubMed ID: 2502066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ.
    Hosaka M; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1731-5. PubMed ID: 7486910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S
    Antimicrob Agents Chemother; 1995 Mar; 39(3):645-9. PubMed ID: 7793866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa.
    Michéa-Hamzehpour M; Furet YX; Pechère JC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2091-7. PubMed ID: 1662023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Hirai K; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):582-6. PubMed ID: 3111356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa.
    Hamzehpour MM; Pechere JC; Plesiat P; Köhler T
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2392-6. PubMed ID: 8585714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical perspectives of quinolone resistance in Pseudomonas aeruginosa.
    Dalhoff A
    Antibiot Chemother (1971); 1991; 44():221-39. PubMed ID: 1801641
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G; Pozzetto B; Dorche G
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa.
    Yoshida T; Muratani T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1466-9. PubMed ID: 7979273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation of the mexT gene, a regulator of the MexEF-oprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa.
    Maseda H; Saito K; Nakajima A; Nakae T
    FEMS Microbiol Lett; 2000 Nov; 192(1):107-12. PubMed ID: 11040437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa.
    Yoneyama H; Ocaktan A; Tsuda M; Nakae T
    Biochem Biophys Res Commun; 1997 Apr; 233(3):611-8. PubMed ID: 9168899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late quinolone resistance in Pseudomonas aeruginosa.
    Smith JM; Hashmi ZS
    J Antimicrob Chemother; 1991 Apr; 27(4):555-6. PubMed ID: 1906859
    [No Abstract]   [Full Text] [Related]  

  • 16. [Causes of quinolone resistance in gram-negative bacteria].
    Cullmann W
    Immun Infekt; 1990 Jun; 18(3):80-8. PubMed ID: 2165997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.
    Young M; Hancock RE
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2365-9. PubMed ID: 1336943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance of Pseudomonas aeruginosa with special reference to new quinolones.
    Iyobe S; Hirai K; Hashimoto H
    Antibiot Chemother (1971); 1991; 44():209-14. PubMed ID: 1801639
    [No Abstract]   [Full Text] [Related]  

  • 19. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Yoshida H; Nakamura M; Bogaki M; Nakamura S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.
    Masecar BL; Celesk RA; Robillard NJ
    Antimicrob Agents Chemother; 1990 Feb; 34(2):281-6. PubMed ID: 2158277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.